# Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

> **NCT05213598** · — · RECRUITING · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 100 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05213598
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-07
- **Primary completion:** 2051-06-30
- **Final completion:** 2051-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05213598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05213598, "Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05213598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*